Multifunctional nanoparticles for drug delivery and molecular imaging

Annual Review of Biomedical Engineering

Volumn 15, Issue , 2013, Pages 253-282

  Bao, Gang ^a   Mitragotri, Samir ^b   Tong, Sheng ^a  

^a Emory University   (United States)

^b University of California   (United States)

Author keywords

cancer therapy; drug delivery; inorganic nanoparticle; molecular imaging; multifunctional nanoparticle

Indexed keywords

BIOMEDICAL APPLICATIONS; CANCER THERAPY; COMPLEX NANOSTRUCTURES; FUNCTIONALIZATIONS; IMAGE GUIDED THERAPY; INORGANIC NANOPARTICLE; MULTI-FUNCTIONAL NANOPARTICLES; MULTI-MODAL IMAGING;

DRUG DELIVERY; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; MOLECULAR IMAGING; NANOPARTICLES;

SYNTHESIS (CHEMICAL);

ACTICOAT; AURIMMUNE; AUROSHELL; COLLOIDAL GOLD; CONTRAST MEDIUM; COPOLYMER; CORNELL DOTS; DENDRIMER; DOXORUBICIN; FERUCARBOTRAN; FERUMOXSIL; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; MITOXANTRONE; NANOCARRIER; NANOCOATING; NANOMATERIAL; NANOTHERM; NBTXR 3; PACLITAXEL; POLYCAPROLACTONE; POLYESTER; POLYLACTIC ACID; POLYMER; QUANTUM DOT; SILVER NANOPARTICLE; SOLID LIPID NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL (TOPIC); DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TARGETING; FLUORESCENCE IMAGING; GENE TARGETING; HUMAN; HYDROGEL; IN VIVO STUDY; KAPOSI SARCOMA; MOLECULAR IMAGING; NANOCHEMISTRY; NANOFABRICATION; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHOTOACOUSTICS; PHOTODYNAMIC THERAPY; REVIEW; SQUAMOUS CELL CARCINOMA;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; GOLD; HUMANS; METAL NANOPARTICLES; MOLECULAR IMAGING; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; PHOTOACOUSTIC TECHNIQUES; POLYMERS; QUANTUM DOTS; SOLVENTS;

EID: 84880568313     PISSN: 15239829     EISSN: 15454274     Source Type: Book Series    
DOI: 10.1146/annurev-bioeng-071812-152409     Document Type: Review

References (212)

1. Davis ME, Chen ZG, Shin DM. 2008. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7:771-82
2. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. 2007. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2:751-60
3. Kim BY, Rutka JT, Chan WC. 2010. Nanomedicine. N. Engl. J. Med. 363:2434-43
4. Hrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, et al. 2012. Preclinical development and clinical translation of a PSMA-Targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci. Transl. Med. 4:128ra39
5. Gratton SE, Williams SS, Napier ME, Pohlhaus PD, Zhou Z, et al. 2008. The pursuit of a scalable nanofabrication platform for use in material and life science applications. Acc. Chem. Res. 41:1685-95
6. Euliss LE, DuPont JA, Gratton S, DeSimone J. 2006. Imparting size, shape, and composition control of materials for nanomedicine. Chem. Soc. Rev. 35:1095-104
7. Roh KH, Martin DC, Lahann J. 2005. Biphasic Janus particles with nanoscale anisotropy. Nat. Mater. 4:759-63
8. Champion JA, Katare YK, Mitragotri S. 2007. Making polymeric micro-And nanoparticles of complex shapes. Proc. Natl. Acad. Sci. USA 104:11901-4
9. Yoo JW, Irvine DJ, Discher DE, Mitragotri S. 2011. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 10:521-35
10. Petros RA, DeSimone JM. 2010. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9:615-27
11. Cleary K, Peters TM. 2010. Image-guided interventions: Technology review and clinical applications. Annu. Rev. Biomed. Eng. 12:119-42
12. Alivisatos P. 2004. The use of nanocrystals in biological detection. Nat. Biotechnol. 22:47-52
13. Champion JA, Katare YK, Mitragotri S. 2007. Particle shape: A new design parameter for micro-And nanoscale drug delivery carriers. J. Control. Release 121:3-9
14. Jana NR, Chen YF, Peng XG. 2004. Size-And shape-controlled magnetic (Cr, Mn, Fe, Co, Ni) oxide nanocrystals via a simple and general approach. Chem. Mater. 16:3931-35
15. Xu Z, Hou Y, Sun S. 2007. Magnetic core/shell Fe3O4/Au and Fe3O4/Au/Ag nanoparticles with tunable plasmonic properties. J. Am. Chem. Soc. 129:8698-99
16. Popovtzer R, Agrawal A, Kotov NA, Popovtzer A, Balter J, et al 2008. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett. 8:4593-96
17. Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL 2007. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett. 7:1929-34
18. Hirsch LR, StaffordRJ, Bankson JA, Sershen SR, Rivera B, et al. 2003. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 100:13549-54
19. Huang XH, El-Sayed IH, Qian W, El-Sayed MA. 2006. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128:2115-20
20. Doshi N, Mitragotri S. 2009. Designer biomaterials for nanomedicine. Adv. Funct. Mater. 19:3843-54
21. IqbalMA, Md S, Sahni JK, Baboota S, Dang S, Ali J. 2012. Nanostructured lipid carriers system: Recent advances in drug delivery. J. Drug Target. 20:813-30
22. Peppas NA, Hilt JZ, Khademhosseini A, Langer R. 2006. Hydrogels in biology and medicine: From molecular principles to bionanotechnology. Adv. Mater. 18:1345-60
23. LiechtyWB, Kryscio DR, Slaughter BV, Peppas NA. 2010. Polymers for drug delivery systems. Annu. Rev. Chem. Biomol. Eng. 1:149-73
24. Panyam J, Labhasetwar V. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55:329-47
25. Vassileva ED, Koseva NS. 2010. Sonochemically born proteinaceous micro-And nanocapsules. Adv. Protein Chem. Struct. Biol. 80:205-52
26. Hans ML, Lowman AM. 2002. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater. Sci. 6:319-27
27. Byrne JD, Betancourt T, Brannon-Peppas L. 2008. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 60:1615-26
28. Doiron AL,Homan KA, Emelianov S, Brannon-Peppas L. 2009. Poly (lactic-co-glycolic) acid as a carrier for imaging contrast agents. Pharm. Res. 26:674-82
29. Canelas DA, Herlihy KP, DeSimone JM. 2009. Top-Down particle fabrication: Control of size and shape for diagnostic imaging and drug delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1:391-404
30. NorthfeltDW, Dezube BJ,Thommes JA, Miller BJ, Fischl MA, et al. 1998. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial. J. Clin. Oncol. 16:2445-51
31. HawkinsMJ, Soon-Shiong P, Desai N. 2008. Protein nanoparticles as drug carriers in clinical medicine. Adv. Drug Deliv. Rev. 60:876-85
32. Wang G, Uludag H. 2008. Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. Expert Opin. Drug Deliv. 5:499-515
33. Green MR, Manikhas GM, Orlov S, Afanasyev B, Makhson AM, et al. 2006. AbraxaneR-, a novel CremophorR- -free, albumin-bound particle form of paclitaxel for the treatment of advanced non-smallcell lung cancer. Ann. Oncol. 17:1263-68
34. Gasco MR. 2007. Lipid nanoparticles: Perspectives and challenges. Adv. Drug Deliv. Rev. 59:377-78
35. Oh KS, Lee KE, Han SS, Cho SH, Kim D, Yuk SH. 2005. Formation of core/shell nanoparticles with a lipid core and their application as a drug delivery system. Biomacromolecules 6:1062-67
36. Lee CC, MacKay JA, Fŕechet JMJ, Szoka FC. 2005. Designing dendrimers for biological applications. Nat. Biotechnol. 23:1517-26
37. Gupta P, Vermani K, Garg S. 2002. Hydrogels: From controlled release to pH-responsive drug delivery. Drug Discov. Today 7:569-79
38. Yoo JW, Doshi N, Mitragotri S. 2011. Adaptive micro and nanoparticles: Temporal control over carrier properties to facilitate drug delivery. Adv. Drug Deliv. Rev. 63:1247-56
39. Pridgen EM, Langer R, Farokhzad OC. 2007. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine (Lond.) 2:669-80
40. Caldorera-Moore M, Peppas NA. 2009. Micro-And nanotechnologies for intelligent and responsive biomaterial-based medical systems. Adv. Drug Deliv. Rev. 61:1391-401
41. Chilkoti A, Dreher MR, Meyer DE, Raucher D. 2002. Targeted drug delivery by thermally responsive polymers. Adv. Drug Deliv. Rev. 54:613-30
42. Li W, Szoka FC Jr. 2007. Lipid-based nanoparticles for nucleic acid delivery. Pharm. Res. 24:438-49
43. Hook AL, Anderson DG, Langer R, Williams P, Davies MC, Alexander MR. 2010. High throughput methods applied in biomaterial development and discovery. Biomaterials 31:187-98
44. Schroeder A,Heller DA, Winslow MM, Dahlman JE, Pratt GW, et al. 2012. Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer 12:39-50
45. Boyer D, Tamarat P, Maali A, Lounis B, Orrit M. 2002. Photothermal imaging of nanometer-sized metal particles among scatterers. Science 297:1160-63
46. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. 2006. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: Applications in biological imaging and biomedicine. J. Phys. Chem. B 110:7238-48
47. Tromberg BJ, Shah N, Lanning R, Cerussi A, Espinoza J, et al. 2000. Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2:26-40
48. Prodan E, Radloff C, Halas NJ, Nordlander P. 2003. A hybridization model for the plasmon response of complex nanostructures. Science 302:419-22
49. Skrabalak SE, Au L, Li XD, Xia YN. 2007. Facile synthesis of Ag nanocubes and Au nanocages. Nat. Protoc. 2:2182-90
50. Halas NJ. 2005. Playing with plasmons. Tuning the optical resonant properties of metallic nanoshells. MRS Bull. 30:362-67
51. Zharov VP,Galitovskaya EN, Johnson C, Kelly T. 2005. Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: Potential for cancer therapy. Lasers Surg. Med. 37:219-26
52. Jain PK, Huang XH, El-Sayed IH, El-Sayed MA. 2008. Noble metals on the nanoscale: Optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc. Chem. Res. 41:1578-86
53. Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, et al. 2008. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 26:83-90
54. Yang X, Stein EW, Ashkenazi S, Wang LV. 2009. Nanoparticles for photoacoustic imaging. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1:360-68
55. Gannon CJ, Patra CR, Bhattacharya R, Mukherjee P, Curley SA. 2008. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J. Nanobiotechnol. 6:2
56. von Maltzahn G, Park JH, Agrawal A, Bandaru NK, Das SK, et al. 2009. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res. 69:3892-900
57. Sun S, Zeng H, Robinson DB, Raoux S, Rice PM, et al. 2004. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J. Am. Chem. Soc. 126:273-79
58. Krishnan KM, Pakhomov AB, Bao Y, Blomqvist P, Chun Y, et al. 2006. Nanomagnetism and spin electronics: Materials, microstructure and novel properties. J. Mater. Sci. 41:793-815
59. Lee JH, Huh YM, Jun YW, Seo JW, Jang JT, et al. 2007. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 13:95-99
60. Jang JT, Nah H, Lee JH, Moon SH, Kim MG, Cheon J. 2009. Critical enhancements of MRI contrast and hyperthermic effects by dopant- controlledmagnetic nanoparticles. Angew. Chem. Int. Ed. 48:1234-38
61. Clement O, Siauve N, Cuenod CA, Frija G. 1998. Liver imaging with ferumoxides (Feridex): Fundamentals, controversies, and practical aspects. Top. Magn. Reson. Imaging 9:167-82
62. Tong S, Hou SJ, Zheng ZL, Zhou J, Bao G 2010. Coating optimization of superparamagnetic iron oxide nanoparticles for high T-2 relaxivity. Nano Lett. 10:4607-13
63. Perez JM, Josephson L,O'Loughlin T, Hogemann D, Weissleder R. 2002. Magnetic relaxation switches capable of sensing molecular interactions. Nat. Biotechnol. 20:816-20
64. Park JH, von Maltzahn G, Zhang L, Schwartz MP, Ruoslahti E, et al. 2008. Magnetic iron oxide nanoworms for tumor targeting and imaging. Adv. Mater. 20:1630-35
65. Rosensweig RE. 2002. Heating magnetic fluid with alternating magnetic field. J. Magn. Magn. Mater. 252:370-74
66. Fortin JP, Wilhelm C, Servais J, Menager C, Bacri JC, Gazeau F. 2007. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J. Am. Chem. Soc. 129:2628-35
67. Lee JH, Jang JT, Choi JS, Moon SH, Noh SH, et al. 2011. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat. Nanotechnol. 6:418-22
68. Dames P, Gleich B, Flemmer A, Hajek K, Seidl N, et al. 2007. Targeted delivery of magnetic aerosol droplets to the lung. Nat. Nanotechnol. 2:495-99
69. Namiki Y, Namiki T, Yoshida H, Ishii Y, Tsubota A, et al. 2009. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat. Nanotechnol. 4:598-606
70. Stanley SA, Gagner JE, Damanpour S, YoshidaM, Dordick JS, Friedman JM. 2012. Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science 336:604-8
71. Cho MH, Lee EJ, Son M, Lee JH, Yoo D, et al. 2012. A magnetic switch for the control of cell death signalling in in vitro and in vivo systems. Nat. Mater. 11:1038-43
72. Alivisatos AP,GuW,LarabellC. 2005. Quantum dots as cellular probes. Annu. Rev. Biomed. Eng. 7:55-76
73. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. 2005. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 4:435-46
74. Hong G, Robinson JT, Zhang Y, Diao S, Antaris AL, et al. 2012. In vivo fluorescence imaging with Ag2S quantum dots in the second near-infrared region. Angew. Chem. Int. Ed. 51:9818-21
75. Wang F, Han Y, Lim CS, Lu YH, Wang J, et al. 2010. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 463:1061-65
76. Auzel F. 2004. Upconversion and anti-Stokes processes with f and d ions in solids. Chem. Rev. 104:139-74
77. Wang F, Liu X. 2008. Upconversion multicolor fine-Tuning: Visible to near-infrared emission from lanthanide-Doped NaYF4 nanoparticles. J. Am. Chem. Soc. 130:5642-43
78. Idris NM, Gnanasammandhan MK, Zhang J, Ho PC, Mahendran R, Zhang Y. 2012. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat. Med. 18:1580-85
79. Piao Y, Burns A, Kim J, WiesnerU,Hyeon T. 2008. Designed fabrication of silica-based nanostructured particle systems for nanomedicine applications. Adv. Funct. Mater. 18:3745-58
80. Epple M, Ganesan K, Heumann R, Klesing J, Kovtun A, et al. 2010. Application of calcium phosphate nanoparticles in biomedicine. J. Mater. Chem. 20:18-23
81. Maggiorella L, Barouch G, Devaux C, Pottier A, Deutsch E, et al. 2012. Nanoscale radiotherapy with hafnium oxide nanoparticles. Future Oncol. 8:1167-81
82. Larson DR, Ow H, Vishwasrao HD, Heikal AA, Wiesner U, Webb WW. 2008. Silica nanoparticle architecture determines radiative properties of encapsulated fluorophores. Chem. Mater. 20:2677-84
83. Barth BM, Sharma R, Altinoglu EI, Morgan TT, Shanmugavelandy SS, et al. 2010. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo. ACS Nano 4:1279-87
84. Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, et al. 2008. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2:889-96
85. Scott AW, Tyler BM, Masi BC, Upadhyay UM, Patta YR, et al. 2011. Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model. Biomaterials 32:2532-39
86. Soppimath KS, AminabhaviTM, Kulkarni AR, RudzinskiWE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70:1-20
87. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, et al. 2007. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28:869-76
88. MacEwan SR, Callahan DJ, Chilkoti A. 2010. Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. Nanomedicine (Lond.) 5:793-806
89. Peppas NA. 2007. Drug delivery using smart polymers: Recent advances. In Smart Polymers: Applications in Biotechnology And Biomedicine, ed. I Galaev, B Mattiasson, pp. 331-58. Boca Raton, FL: CRC
90. Schmaljohann D. 2006. Thermo-And pH-responsive polymers in drug delivery. Adv. Drug Deliv. Rev. 58:1655-70
91. Geest BGD, Sanders NN, Sukhorukov GB, Demeester J, Smedt SCD. 2007. Release mechanisms for polyelectrolyte capsules. Chem. Soc. Rev. 36:636-49
92. HeffernanMJ, Murthy N. 2005. Polyketal nanoparticles: A new pH-sensitive biodegradable drug delivery vehicle. Bioconjug. Chem. 16:1340-42
93. Cammas S, Suzuki K, Sone C, Sakurai Y, Kataoka K, Okano T. 1997. Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers. J. Control. Release 48:157-64
94. Sershen SR, Westcott SL, Halas NJ, West JL. 2000. Temperature-sensitive polymer-nanoshell composites for photothermally modulated drug delivery. J. Biomed. Mater. Res. 51:293-98
95. Qu LH, Peng ZA, Peng XG 2001. Alternative routes toward high quality CdSe nanocrystals. Nano Lett. 1:333-37
96. Hyeon T, Park J, An KJ, Hwang YS, Park JG, et al. 2004. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat. Mater. 3:891-95
97. Xie J,XuC,KohlerN,Hou Y, Sun S. 2007. ControlledPEGylation ofmonodisperse Fe3O4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv. Mater. 19:3163-66
98. Lattuada M, Hatton TA. 2007. Functionalization of monodisperse magnetic nanoparticles. Langmuir 23:2158-68
99. Smith AM, Nie S. 2008. Minimizing the hydrodynamic size of quantum dots with multifunctional multidentate polymer ligands. J. Am. Chem. Soc. 130:11278-79
100. Gittins DI, Caruso F. 2002. Biological and physical applications of water-based metal nanoparticles synthesised in organic solution. Chemphyschem 3:110-13
101. Pellegrino T, Manna L, Kudera S, Liedl T, Koktysh D, et al. 2004. Hydrophobic nanocrystals coated with an amphiphilic polymer shell: A general route to water soluble nanocrystals. Nano Lett. 4:703-7
102. Tong S, Hou S, Ren B, Zheng Z, Bao G 2011. Self-Assembly of phospholipid-PEG coating on nanoparticles through dual solvent exchange. Nano Lett. 11:3720-26
103. Yu WW, Chang E, Sayes CM, Drezek R, Colvin VL. 2006. Aqueous dispersion of monodisperse magnetic iron oxide nanocrystals through phase transfer. Nanotechnology 17:4483-87
104. Ariga K,Hill JP, JiQ. 2007. Layer-by-layer assembly as a versatile bottom-up nanofabrication technique for exploratory research and realistic application. Phys. Chem. Chem. Phys. 9:2319-40
105. Sinha A, Jana NR. 2012. Nanoparticle-incorporated functional mesoporous silica colloid for diverse applications. Eur. J. Inorg. Chem. 2012:4470-78
106. Kim J, Kim HS, Lee N, Kim T, Kim H, et al. 2008. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. Int. Ed. 47:8438-41
107. Park YI, Kim JH, Lee KT, Jeon KS, Bin Na H, et al. 2009. Nonblinking and nonbleaching upconverting nanoparticles as an optical imaging nanoprobe and T1 magnetic resonance imaging contrast agent. Adv. Mater. 21:4467-71
108. Wang C, Yin HF, Dai S, Sun SH. 2010. A general approach to noble metal-metal oxide dumbbell nanoparticles and their catalytic application for CO oxidation. Chem. Mater. 22:3277-82
109. Lyon JL, Fleming DA, Stone MB, Schiffer P, Williams ME 2004. Synthesis of Fe oxide core/Au shell nanoparticles by iterative hydroxylamine seeding. Nano Lett. 4:719-23
110. Choi JS, Lee JH, Shin TH, Song HT, Kim EY, Cheon J. 2010. Self-confirming "AND" logic nanoparticles for fault-free MRI. J. Am. Chem. Soc. 132:11015-17
111. Jin Y, Jia C, Huang SW, O'Donnell M, Gao X. 2010. Multifunctional nanoparticles as coupled contrast agents. Nat. Commun. 1:41
112. Kim J, Park S, Lee JE, Jin SM, Lee JH, et al. 2006. Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew. Chem. Int. Ed. 45:7754-58
113. Qu HO,MaH, Riviere A, Zhou WL,O'Connor CJ. 2012. One-pot synthesis in polyamines for preparation of water-soluble magnetite nanoparticles with amine surface reactivity. J. Mater. Chem. 22:3311-13
114. NashMA,Yager P, HoffmanAS, StaytonPS. 2010. Mixed stimuli-responsive magnetic and gold nanoparticle system for rapid purification, enrichment, and detection of biomarkers. Bioconjug. Chem. 21:2197-204
115. Park JH, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ. 2008. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew. Chem. Int. Ed. 47:7284-88
116. Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, et al 2006. Multifunctional polymeric micelles as cancer-Targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 6:2427-30
117. Zintchenko A, Susha AS, Concia M, Feldmann J, Wagner E, et al. 2009. Drug nanocarriers labeled with near-infrared-emitting quantum dots (quantoplexes): Imaging fast dynamics of distribution in living animals. Mol. Ther. 17:1849-56
118. Liu Z, Yi G, Zhang H, Ding J, Zhang Y, Xue J. 2008. Monodisperse silica nanoparticles encapsulating upconversion fluorescent and superparamagnetic nanocrystals. Chem. Commun.(6):694-96
119. BenezraM, Penate-Medina O, Zanzonico PB, Schaer D, Ow H, et al. 2011. Multimodal silica nanoparticles are effective cancer-Targeted probes in a model of human melanoma. J. Clin. Invest. 121:2768-80
120. Xie J, Chen K, Huang J, Lee S, Wang JH, et al. 2010. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 31:3016-22
121. Jain TK,Richey J, Strand M, Leslie-Pelecky DL, FlaskCA, LabhasetwarV. 2008. Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging. Biomaterials 29:4012-21
122. Lai CY, Trewyn BG, Jeftinija DM, Jeftinija K, Xu S, et al. 2003. A mesoporous silica nanosphere-based carrier system with chemically removableCdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 125:4451-59
123. Mal NK, Fujiwara M, Tanaka Y. 2003. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature 421:350-53
124. Bharali DJ, Klejbor I, Stachowiak EK, Dutta P, Roy I, et al. 2005. Organically modified silica nanoparticles: A nonviral vector for in vivo gene delivery and expression in the brain. Proc. Natl. Acad. Sci. USA 102:11539-44
125. Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VSY. 2004. A polyamidoamine dendrimercapped mesoporous silica nanosphere-based gene transfection reagent. J. Am. Chem. Soc. 126:13216-17
126. Juliano RL, Stamp D. 1975. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem. Biophys. Res. Commun. 63:651-58
127. Stolnik S, Illum L, Davis SS. 1995. Long circulating microparticulate drug carriers. Adv. Drug Deliv. Rev. 16:195-214
128. Moghimi SM, Hunter AC,Murray JC. 2001. Long-circulating and target-specific nanoparticles: Theory to practice. Pharm. Rev. 53:283-318
129. Moghimi S,Hunter A. 2000. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol. 18:412-20
130. Arap W, Pasqualini R, Ruoslahti E. 1998. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279:377-80
131. Ruoslahti E, Bhatia SN, Sailor MJ. 2010. Targeting of drugs and nanoparticles to tumors. J. Cell Biol. 188:759-68
132. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, et al. 2006. Targeted nanoparticle-Aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. USA 103:6315-20
133. Pangburn TO, Petersen MA, Waybrant B, Adil MM, Kokkoli E. 2009. Peptide-And aptamerfunctionalized nanovectors for targeted delivery of therapeutics. J. Biomech. Eng. 131:074005
134. Barbas AS, Mi J, Clary BM, White RR. 2010. Aptamer applications for targeted cancer therapy. Future Oncol. 6:1117-26
135. Sudimack J, LeeRJ. 2000. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 41:147-62
136. MiY, LiuX,Zhao J,Ding J, Feng SS. 2012. Multimodality treatment of cancerwith herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers. Biomaterials 33:7519-29
137. Gu F, Zhang L, Teply BA,Mann N,Wang A, et al. 2008. Precise engineering of targeted nanoparticles by using self-Assembled biointegrated block copolymers. Proc. Natl. Acad. Sci. USA 105:2586-91
138. Roh KH, Martin DC, Lahann J. 2006. Triphasic nanocolloids. J. Am. Chem. Soc. 128:6796-97
139. Beningo K,Wang Y. 2002. Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J. Cell Sci. 115:849-56
140. Gratton SEA, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, et al. 2008. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. USA 105:11613-18
141. Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, et al. 2007. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2:249-55
142. Champion JA, Mitragotri S. 2006. From the cover: Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. USA 103:4930-34
143. Champion JA, Mitragotri S. 2009. Shape induced inhibition of phagocytosis of polymer particles. Pharm. Res. 26:244-49
144. Decuzzi P, Godin B, Tanaka T, Lee SY, Chiappini C, et al. 2010. Size and shape effects in the biodistribution of intravascularly injected particles. J. Control. Release 141:320-27
145. Decuzzi P, Ferrari M. 2006. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 27:5307-14
146. Decuzzi P, Gentile F, Granaldi A, Curcio A, Causa F, et al. 2007. Flow chamber analysis of size effects in the adhesion of spherical particles. Int. J. Nanomed. 2:689-96
147. Yin Y, Lu Y, Gates B, Xia Y. 2001. Template-Assisted self-Assembly: A practical route to complex aggregates of monodispersed colloids with well-Defined sizes, shapes, and structures. J. Am. Chem. Soc. 123:8718-29
148. Dendukuri D, Pregibon D, Collins J, Hatton T, Doyle P. 2006. Continuous-flow lithography for highthroughput microparticle synthesis. Nat. Mater. 5:365-69
149. Rolland JP, Maynor BW, Euliss LE, Exner AE, Denison GM, DeSimone JM. 2005. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J. Am. Chem. Soc. 127:10096-100
150. Lee KJ, Yoon J, Lahann J. 2011. Recent advances with anisotropic particles. Curr. Opin. Colloid Interface Sci. 16:195-202
151. Cunningham CH, Arai T, Yang PC, McConnell MV, Pauly JM, Conolly SM. 2005. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn. Reson.Med. 53:999-1005
152. Zurkiya O, Hu XP. 2006. Off-resonance saturation as a means of generating contrast with superparamagnetic nanoparticles. Magnet. Reson. Med. 56:726-32
153. Shin JM, Anisur RM, Ko MK, Im GH, Lee JH, Lee IS. 2009. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew. Chem. Int. Ed. 48:321-24
154. Harisinghani MG, Barentsz J,Hahn PF, DesernoWM, Tabatabaei S, et al. 2003. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348:2491-99
155. Zhao M, Beauregard DA, Loizou L,Davletov B, Brindle KM. 2001. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat. Med. 7:1241-44
156. Ghosh D, Lee Y, Thomas S, Kohli AG, Yun DS, et al. 2012. M13-Templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. Nat. Nanotechnol. 7:677-82
157. Fan K, Cao C, Pan Y, Lu D, Yang D, et al. 2012. Magnetoferritin nanoparticles for targeting and visualizing tumour tissues. Nat. Nanotechnol. 7:459-64
158. Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, et al. 2006. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114:1504-11
159. Bruns OT, Ittrich H, Peldschus K, KaulMG, Tromsdorf UI, et al. 2009. Real-Time magnetic resonance imaging and quantification of lipoproteinmetabolism in vivo using nanocrystals. Nat. Nanotechnol. 4:193-201
160. Kessinger CW, Togao O, Khemtong C, Huang G, Takahashi M, Gao J. 2011. Investigation of in vivo targeting kinetics of αvβ3-specific superparamagnetic nanoprobes by time-resolved MRI. Theranostics 1:263-73
161. Tang T, Howarth SP, Miller SR, Trivedi R, Graves MJ, et al. 2006. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke. 37:2266-70
162. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, et al. 2000. Tat peptide-Derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18:410-14
163. Thu MS, Bryant LH, Coppola T, Jordan EK, Budde MD, et al. 2012. Self-Assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking bymagnetic resonance imaging. Nat. Med. 18:463-67
164. Barnett BP, Arepally A, Karmarkar PV, Qian D, Gilson WD, et al. 2007. Magnetic resonance-guided, real-Time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat. Med. 13:986-91
165. Sevick-Muraca EM. 2012. Translation of near-infrared fluorescence imaging technologies: Emerging clinical applications. Annu. Rev. Med. 63:217-31
166. Kim S, Lim YT, Soltesz EG,DeGrand AM, Lee J, et al. 2004. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 22:93-97
167. Du Y, Xu B, Fu T, Cai M, Li F, et al. 2010. Near-infrared photoluminescent Ag2S quantum dots from a single source precursor. J. Am. Chem. Soc. 132:1470-71
168. Xiong L, Chen Z, Tian Q, Cao T, Xu C, Li F. 2009. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors. Anal. Chem. 81:8687-94
169. Cheng L, Yang K, Shao M, Lee ST, Liu Z. 2011. Multicolor in vivo imaging of upconversion nanoparticles with emissions tuned by luminescence resonance energy transfer. J. Phys. Chem. C 115:2686-92
170. Chen J, Saeki F, Wiley BJ, Cang H, Cobb MJ, et al. 2005. Gold nanocages: Bioconjugation and their potential use as optical imaging contrast agents. Nano Lett. 5:473-77
171. Zhang HF, Maslov K, Stoica G, Wang LV. 2006. Functional photoacoustic microscopy for highresolution and noninvasive in vivo imaging. Nat. Biotechnol. 24:848-51
172. Wang Y, Xie X,Wang X, Ku G, Gill KL, et al 2004. Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain. Nano Lett. 4:1689-92
173. Yang X, Skrabalak SE, Li ZY, Xia Y,Wang LV 2007. Photoacoustic tomography of a rat cerebral cortex in vivo with Au nanocages as an optical contrast agent. Nano Lett. 7:3798-802
174. Mallidi S, Larson T, Aaron J, Sokolov K, Emelianov S. 2007. Molecular specific optoacoustic imaging with plasmonic nanoparticles. Opt. Express 15:6583-88
175. Li PC, Wei CW, Liao CK, Chen CD, Pao KC, et al. 2007. Photoacoustic imaging of multiple targets using gold nanorods. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 54:1642-47
176. Galanzha EI, Shashkov EV, Kelly T, Kim JW, Yang L, Zharov VP. 2009. In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. Nat. Nanotechnol. 4:855-60
177. Mallidi S, Larson T, Tam J, Joshi PP, Karpiouk A, et al 2009. Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer. Nano Lett. 9:2825-31
178. Kim G, Huang SW, Day KC, O'Donnell M, Agayan RR, et al. 2007. Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging. J. Biomed. Opt. 12:044020
179. Pan D, Cai X, Yalaz C, Senpan A, Omanakuttan K, et al. 2012. Photoacoustic sentinel lymph node imaging with self-Assembled copper neodecanoate nanoparticles. ACS Nano 6:1260-67
180. Ku G, Zhou M, Song S, Huang Q, Hazle J, Li C. 2012. Copper sulfide nanoparticles as a new class of photoacoustic contrast agent for deep tissue imaging at 1064 nm. ACS Nano 6:7489-96
181. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L. 2003. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 63:8122-25
182. Lin X, Xie J, Niu G, Zhang F, Gao H, et al 2011. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett. 11:814-19
183. Xia A, Chen M, Gao Y, Wu D, Feng W, Li F. 2012. Gd3+ complex-modified NaLuF4-based upconversion nanophosphors for trimodality imaging of NIR-To-NIR upconversion luminescence, X-ray computed tomography and magnetic resonance. Biomaterials 33:5394-405
184. Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, et al. 2012. A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat. Med. 18:829-34
185. Nahrendorf M, Zhang H, Hembrador S, Panizzi P, Sosnovik DE, et al. 2008. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 117:379-87
186. Lee HY, Li Z, Chen K, Hsu AR, Xu C, et al. 2008. PET/MRI dual-modality tumor imaging using arginine-glycine-Aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J. Nucl. Med. 49:1371-79
187. Jain RK. 2001. Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev. 46:149-68
188. Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. 2008. New frontiers in nanotechnology for cancer treatment. Urol. Oncol. 26:74-85
189. Wang AZ, Langer R, Farokhzad OC. 2012. Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 63:185-98
190. Galvin P, Thompson D, Ryan KB, McCarthy A, Moore AC, et al. 2012. Nanoparticle-based drug delivery: Case studies for cancer and cardiovascular applications. Cell. Mol. Life Sci. 69:389-404
191. Leleux J, Roy K. 2013. Micro and nanoparticle-based delivery systems for vaccine immunotherapy: An immunological and materials perspective. Adv. Healthc. Mater. 2:72-94
192. Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR, Tsourkas A. 2012. Multifunctional nanoparticles: Cost versus benefit of adding targeting and imaging capabilities. Science 338:903-10
193. NobutoH, Sugita T, Kubo T, Shimose S, Yasunaga Y, et al. 2004. Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet. Int. J. Cancer 109:627-35
194. Medarova Z, Pham W, Farrar C, Petkova V, Moore A. 2007. In vivo imaging of siRNA delivery and silencing in tumors. Nat. Med. 13:372-77
195. Cho NH, Cheong TC, Min JH, Wu JH, Lee SJ, et al. 2011. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat. Nanotechnol. 6:675-82
196. Viglianti BL, Abraham SA, Michelich CR, Yarmolenko PS, MacFall JR, et al. 2004. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery. Magn. Reson. Med. 51:1153-62
197. Medarova Z, Rashkovetsky L, Pantazopoulos P, Moore A. 2009. Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging. Cancer Res. 69:1182-89
198. Furlani EP, Ng KC. 2008. Nanoscale magnetic biotransport with application to magnetofection. Phys. Rev. E 77:061914
199. Shapiro B. 2009. Towards dynamic control of magnetic fields to focus magnetic carriers to targets deep inside the body. J. Magn. Magn. Mater. 321:1594-99
200. Yellen BB, Forbes ZG, Halverson DS, Fridman G, Barbee KA, et al. 2005. Targeted drug delivery to magnetic implants for therapeutic applications. J. Magn. Magn. Mater. 293:647-54
201. Widder KJ, Senyel AE, Scarpelli GD. 1978. Magnetic microspheres: A model system of site specific drug delivery in vivo. Proc. Soc. Exp. Biol. Med. 158:141-46
202. Widder KJ, Morris RM, Poore GA, Howard DP, Senyei AE. 1983. Selective targeting of magnetic albumin microspheres containing low-Dose doxorubicin: Total remission in Yoshida sarcoma-bearing rats. Eur. J. Cancer Clin. Oncol. 19:135-39
203. Rudge S, Peterson C, Vessely C, Koda J, Stevens S, Catterall L. 2001. Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). J. Control. Release 74:335-40
204. Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, et al. 2000. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 60:6641-48
205. Chorny M, Fishbein I, Yellen BB, Alferiev IS, Bakay M, et al. 2010. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proc. Natl. Acad. Sci. USA 107:8346-51
206. Hofmann A,WenzelD, BecherUM, FreitagDF, Klein AM, et al. 2009. Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc. Natl. Acad. Sci. USA 106:44-49
207. Cheng K, Malliaras K, Li TS, Sun B, Houde C, et al. 2012. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-Derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant. 21:1121-35
208. Kong G, Braun RD, DewhirstMW.2001. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res. 61:3027-32
209. Hu SH, Chen SY, Liu DM, Hsiao CS. 2008. Core/single-crystal-shell nanospheres for controlled drug release via a magnetically triggered rupturing mechanism. Adv. Mater. 20:2690-95
210. Thomas CR, Ferris DP, Lee JH, Choi E, Cho MH, et al. 2010. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J. Am. Chem. Soc. 132:10623-25
211. Derfus AM, von Maltzahn G, Harris TJ, Duza T, Vecchio KS, et al. 2007. Remotely triggered release from magnetic nanoparticles. Adv. Mater. 19:3932-36
212. Lu W, Zhang G, Zhang R, Flores LG, Huang Q, et al. 2010. Tumor site-specific silencing of NF-κB p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res. 70:3177-88 Excellence in Nanotechnology Award Center